303 related articles for article (PubMed ID: 26382298)
1. Purinergic signaling during macrophage differentiation results in M2 alternative activated macrophages.
Barberà-Cremades M; Baroja-Mazo A; Pelegrín P
J Leukoc Biol; 2016 Feb; 99(2):289-99. PubMed ID: 26382298
[TBL] [Abstract][Full Text] [Related]
2. The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Rα) signaling.
Ferrante CJ; Pinhal-Enfield G; Elson G; Cronstein BN; Hasko G; Outram S; Leibovich SJ
Inflammation; 2013 Aug; 36(4):921-31. PubMed ID: 23504259
[TBL] [Abstract][Full Text] [Related]
3. Nucleotide receptor signaling in murine macrophages is linked to reactive oxygen species generation.
Pfeiffer ZA; Guerra AN; Hill LM; Gavala ML; Prabhu U; Aga M; Hall DJ; Bertics PJ
Free Radic Biol Med; 2007 May; 42(10):1506-16. PubMed ID: 17448897
[TBL] [Abstract][Full Text] [Related]
4. Purinergic receptor regulation of LPS-induced signaling and pathophysiology.
Guerra AN; Fisette PL; Pfeiffer ZA; Quinchia-Rios BH; Prabhu U; Aga M; Denlinger LC; Guadarrama AG; Abozeid S; Sommer JA; Proctor RA; Bertics PJ
J Endotoxin Res; 2003; 9(4):256-63. PubMed ID: 12935357
[TBL] [Abstract][Full Text] [Related]
5. Spleen-derived macrophages are readily polarized into classically activated (M1) or alternatively activated (M2) states.
Mulder R; Banete A; Basta S
Immunobiology; 2014 Oct; 219(10):737-45. PubMed ID: 24954891
[TBL] [Abstract][Full Text] [Related]
6. Involvement of purinergic system in the release of cytokines by macrophages exposed to glioma-conditioned medium.
Bergamin LS; Braganhol E; Figueiró F; Casali EA; Zanin RF; Sévigny J; Battastini AM
J Cell Biochem; 2015 May; 116(5):721-9. PubMed ID: 25546398
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: purinergic signaling regulates radical-mediated bacterial killing mechanisms in macrophages through a P2X7-independent mechanism.
Sikora A; Liu J; Brosnan C; Buell G; Chessel I; Bloom BR
J Immunol; 1999 Jul; 163(2):558-61. PubMed ID: 10395640
[TBL] [Abstract][Full Text] [Related]
8. Treatment in vitro with PPARα and PPARγ ligands drives M1-to-M2 polarization of macrophages from T. cruzi-infected mice.
Penas F; Mirkin GA; Vera M; Cevey Á; González CD; Gómez MI; Sales ME; Goren NB
Biochim Biophys Acta; 2015 May; 1852(5):893-904. PubMed ID: 25557389
[TBL] [Abstract][Full Text] [Related]
9. IFN-gamma up-regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deactivation.
Xaus J; Mirabet M; Lloberas J; Soler C; Lluis C; Franco R; Celada A
J Immunol; 1999 Mar; 162(6):3607-14. PubMed ID: 10092821
[TBL] [Abstract][Full Text] [Related]
10. Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.
Wirkner K; Schweigel J; Gerevich Z; Franke H; Allgaier C; Barsoumian EL; Draheim H; Illes P
Br J Pharmacol; 2004 Jan; 141(1):141-51. PubMed ID: 14662731
[TBL] [Abstract][Full Text] [Related]
11. Uptake of neutrophil-derived Ym1 protein distinguishes wound macrophages in the absence of interleukin-4 signaling in murine wound healing.
Goren I; Pfeilschifter J; Frank S
Am J Pathol; 2014 Dec; 184(12):3249-61. PubMed ID: 25307347
[TBL] [Abstract][Full Text] [Related]
12. Autocrine regulation of macrophage activation via exocytosis of ATP and activation of P2Y11 receptor.
Sakaki H; Tsukimoto M; Harada H; Moriyama Y; Kojima S
PLoS One; 2013; 8(4):e59778. PubMed ID: 23577075
[TBL] [Abstract][Full Text] [Related]
13. Extracellular mycobacterial DnaK polarizes macrophages to the M2-like phenotype.
Lopes RL; Borges TJ; Araújo JF; Pinho NG; Bergamin LS; Battastini AM; Muraro SP; Souza AP; Zanin RF; Bonorino C
PLoS One; 2014; 9(11):e113441. PubMed ID: 25419575
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition and augmentation of alternative macrophage activation by progesterone.
Menzies FM; Henriquez FL; Alexander J; Roberts CW
Immunology; 2011 Nov; 134(3):281-91. PubMed ID: 21977998
[TBL] [Abstract][Full Text] [Related]
15. Purinergic signaling in kidney disease.
Menzies RI; Tam FW; Unwin RJ; Bailey MA
Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
[TBL] [Abstract][Full Text] [Related]
16. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
17. TIGIT negatively regulates inflammation by altering macrophage phenotype.
Chen X; Lu PH; Liu L; Fang ZM; Duan W; Liu ZL; Wang CY; Zhou P; Yu XF; He WT
Immunobiology; 2016 Jan; 221(1):48-55. PubMed ID: 26307002
[TBL] [Abstract][Full Text] [Related]
18. Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states.
Donnelly-Roberts DL; Jarvis MF
Br J Pharmacol; 2007 Jul; 151(5):571-9. PubMed ID: 17471177
[TBL] [Abstract][Full Text] [Related]
19. Purinergic receptors in gastrointestinal inflammation.
Kolachala VL; Bajaj R; Chalasani M; Sitaraman SV
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G401-10. PubMed ID: 18063703
[TBL] [Abstract][Full Text] [Related]
20. Regulation of sialoadhesin expression on rat macrophages. Induction by glucocorticoids and enhancement by IFN-beta, IFN-gamma, IL-4, and lipopolysaccharide.
van den Berg TK; van Die I; de Lavalette CR; Döpp EA; Smit LD; van der Meide PH; Tilders FJ; Crocker PR; Dijkstra CD
J Immunol; 1996 Oct; 157(7):3130-8. PubMed ID: 8816424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
